Literature DB >> 2660786

In vitro and in vivo activity of chymotrypsin-activated big endothelin (porcine 1-40).

E G McMahon1, K F Fok, W M Moore, C E Smith, N R Siegel, A J Trapani.   

Abstract

We investigated whether big endothelin (porcine 1-40) had contractile activity in isolated rat aorta or pressor activity when injected intravenously into the anesthetized rat. When isolated rat aorta was exposed to a 100 nM concentration of big endothelin, 4.8% of a maximal KCl contraction was observed, compared to 131% of KClmax when paired aortic rings were exposed to an equivalent concentration of synthetic endothelin. Likewise, big endothelin had very weak pressor activity when injected intravenously into anesthetized, ganglion-blocked rats at 10 nmol/kg. When big endothelin was incubated with chymotrypsin, native endothelin and other peptide fragments were formed. Chymotrypsin-treated big endothelin produced an endothelin-like contraction when applied to isolated rat aortic rings, and a characteristic endothelin-like effect on blood pressure in vivo. Our results indicate that the biological activity of endothelin could be effectively blocked by inhibiting the enzyme which converts big endothelin to endothelin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660786     DOI: 10.1016/0006-291x(89)92613-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  125I-endothelin-1 and 125I-big endothelin-1 in rat tissues: autoradiographic localization and receptor binding.

Authors:  D Neuser; W Steinke; H Dellweg; S Kazda; J P Stasch
Journal:  Histochemistry       Date:  1991

2.  Mode of cleavage of pig big endothelin-1 by chymotrypsin. Production and degradation of mature endothelin-1.

Authors:  M Takaoka; Y Miyata; Y Takenobu; R Ikegawa; Y Matsumura; S Morimoto
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides.

Authors:  M S Fabbrini; A Vitale; C Patrono; M Zamai; F Vaghi; V Caiolfa; L Monaco; L Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.

Authors:  P D'Orléans-Juste; S Télémaque; A Claing
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

5.  The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.

Authors:  S Kaw; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

Authors:  E G McMahon; M A Palomo; W M Moore; J F McDonald; M K Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.